Active Ingredient History

  • Now
Lesogaberan (AZD-3355) was an experimental drug candidate developed by AstraZeneca for the treatment of gastroesophageal reflux disease (GERD). As a GABAB receptor agonist, it has the same mechanism of action as baclofen, but is anticipated to have fewer of the central nervous system side effects that limit the clinical use of baclofen for the treatment of GERD.   Wikipedia

  • SMILES: NC[C@@H](F)CP(=O)O
  • Mol. Mass: 141.08
  • ALogP: -0.25
  • ChEMBL Molecule:
More Chemistry
azd3355 | azd 3355 | azd-3355 | lesogaberan


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue